Jazzed Up for American Heart Association 2025 in New Orleans

Craig Beavers and Kyle Fischer, PharmD, BCCP, MBA, discuss key late-breaking cardiovascular trials expected at the American Heart Association’s upcoming annual meeting, exploring their clinical relevance and implications for pharmacists.

• POLY-HF Trial
• CELEBRATE Trial
• VESALIUS-CV Trial